Balaxi Pharma Reports Nil Physical Share Transfers Sept 2026

Date: 07th October, 2026

Compliance Disclosure

Balaxi Pharmaceuticals Limited submitted a regulatory compliance report to the National Stock Exchange of India Limited regarding physical share transfer requests, as mandated by SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/ I/3750/2026 dated 30th January, 2026.

The report, prepared by the company's Registrar and Share Transfer Agent, M/s. Aarthi Consultants Private Limited (SEBI Registration No: INIRBOSEJ00319), covers the period ended September 2026.

Physical Share Transfer Request Status

The report indicates nil activity for all metrics during September 2026:

• Number of requests received during the month: NIL
• Number of requests processed during the month: NIL
• Number of requests approved during the month: NIL
• Number of requests rejected during the month: NIL
• Average time taken for processing of requests: NA (not applicable)

Additional Information

The report is signed by Aman Purohit, Company Secretary & Compliance Officer of Balaxi Pharmaceuticals Limited (ICSI Membership No.: A59345), and Jagan Mohan Gobburi, Compliance Officer of Aarthi Consultants Private Limited.

The document states that this information will also be available on the company's website at www.balaxipharma.in.